3 Electronic Agent Accountability Record

Investigational Agent Accountability Record Forms in the Conduct of Investigational Trials in Cancer Treatment (NCI)

Attachment 3 - Electronic Agent Accountability Record Form (1)

OMB: 0925-0613

Document [pdf]
Download: pdf | pdf
Attachment A3: Electronic Agent Accountability Record Form
Form Approved: OMB No: 0925-0613
Expires: 03/31/2022
Collection of this information is authorized under 21.CRF.312.57. This information is collected to ensure compliance with Food and Drug Administration (FDA) requirements for NCI as an IND sponsor and that
investigational agents are under the control and accounted for by competent authority. The information may be disclosed to researchers for investigational purposes, sponsors of clinical trials and their
company collaborators, the applicable Institutional Review Board, NCI, FDA, and Department of Health and Human Services. Submission of this information is voluntary, however, in order for you to conduct a
study in accordance with relevant, current protocols, you must complete all fields.
Public reporting burden for this collection of information is estimated to average 1 minute per response, including the time for reviewing instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless
it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to NIH
Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN PRA (0925-0613). Do not return the completed form to this address.

Link to OMB Burden Statement


File Typeapplication/pdf
AuthorMartha Hering
File Modified2021-04-26
File Created2021-04-26

© 2024 OMB.report | Privacy Policy